Análisis de la acción Crown Reserve Acquisition Corp. I (CRAC)

AI analysis of Crown Reserve Acquisition Corp. I (CRAC)

hold

Crown Reserve Acquisition Corp. I (CRAC) is currently trading at $10.19, which is close to its 200-day simple moving average of $10.05. The stock has shown a 1-year change of +2.93%, indicating stability, but the forward P/E ratio is 0, suggesting uncertainty in future earnings. The RSI is at 52.68, indicating a neutral momentum. The main risk is the negative net income reported in Q1 2026 of -263,493 USD, which raises concerns about profitability. Given these factors, it is prudent to hold rather than buy at this time.

Métricas de valoración

The current forward P/E ratio for Crown Reserve Acquisition Corp. I (CRAC) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E

Current P/E

0.00

Forward EV/EBITDA

5Y Average EV/EBITDA

Current EV/EBITDA

0.00

Forward P/S

5Y Average P/S

Current P/S

0.00

Whales holding CRAC

P

Polar Asset Management Partners Inc.

+ HoldingCRAC

-1.52%

3M Return

CRAC FAQ — answered by Alphio AI

Crown Reserve Acquisition Corp I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focused industries include pharma, medical technology and medical equipment, and healthcare information technology (IT) industries. The Company is not engaged in any business operation and does not have any revenues. It operates in the Financials sector.

Crown Reserve Acquisition Corp. I (CRAC) is currently trading at $10.19, which is close to its 200-day simple moving average of $10.05. The stock has shown a 1-year change of +2.93%, indicating stability, but the forward P/E ratio is 0, suggesting uncertainty in future earnings. The RSI is at 52.68, indicating a neutral momentum. The main risk is the negative net income reported in Q1 2026 of -263,493 USD, which raises concerns about profitability. Given these factors, it is prudent to hold rather than buy at this time.